These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7982297)

  • 1. Can our health services be saved by technology evaluation? The Quebec experience.
    McGregor M
    Clin Invest Med; 1994 Aug; 17(4):334-42. PubMed ID: 7982297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reports from the Conseil d'Evaluation des Technologies de la Santé du Québec (CETS). The safety of dental amalgam: a state-of-the-art review.
    Int J Technol Assess Health Care; 1997; 13(4):639-42. PubMed ID: 9489256
    [No Abstract]   [Full Text] [Related]  

  • 3. Reports from the Conseil d'évaluation des Technologies de la Santé du Québec. Hemodialyzer reuse: considerations of safety and cost.
    Int J Technol Assess Health Care; 1991; 7(4):639-40. PubMed ID: 1778710
    [No Abstract]   [Full Text] [Related]  

  • 4. Reports from the Conseil d'Evaluation des Technologies de la Santé du Québec (CETS). The cochlear implant in adults, adolescents, and children.
    Int J Technol Assess Health Care; 1997; 13(4):642-5. PubMed ID: 9527532
    [No Abstract]   [Full Text] [Related]  

  • 5. Technology briefs from the Conseil d'Evaluation des Technologies de la Santé du Québec (CETS). Diathermy and balloon dialatation treatment of benign prostatic hypertrophy.
    Int J Technol Assess Health Care; 1993; 9(4):593-5. PubMed ID: 7507097
    [No Abstract]   [Full Text] [Related]  

  • 6. Reports from the Conseil d'Evaluation des Technologies de la Santé du Québec (CETS). Percutaneous transluminal coronary angioplasty: update of application and standards for utilization.
    Int J Technol Assess Health Care; 1997; 13(4):646-7. PubMed ID: 9527533
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of technology on health care cost and policy development.
    Wallner PE; Konski A
    Semin Radiat Oncol; 2008 Jul; 18(3):194-200. PubMed ID: 18513629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report from the Conseil d'Evaluation des Technologies de la Santé (CETS). Mandate of the conseil.
    Int J Technol Assess Health Care; 1992; 8(2):366. PubMed ID: 1628918
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of health technology assessment in the comprehensive evaluation of the impact of immunotherapy on real practice.
    Frati F; Ariano R; Cadario G; Ortolani C; Passalacqua G
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():4-6. PubMed ID: 18924459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling wastage and inefficiency in the health sector.
    Parker D; Newbrander W
    World Health Forum; 1994; 15(2):107-13; discussion 114-31. PubMed ID: 8018273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The medical technologist and evaluation of health technologies.
    Peddecord KM
    Am J Med Technol; 1980 Jan; 46(1):30-2. PubMed ID: 7352464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reports from the Conseil D'évaluation des Technologies de la Santé du Québec. Screening for breast cancer in Quebec: estimates of health effects and costs.
    Int J Technol Assess Health Care; 1991; 7(4):638-9. PubMed ID: 1778709
    [No Abstract]   [Full Text] [Related]  

  • 15. Report from the Conseil d'Evaluation des Technologies de la Santé du Québec (CETS).
    Int J Technol Assess Health Care; 1995; 11(3):629-31. PubMed ID: 7591561
    [No Abstract]   [Full Text] [Related]  

  • 16. End-user involvement in health technology assessment (HTA) development: a way to increase impact.
    McGregor M; Brophy JM
    Int J Technol Assess Health Care; 2005; 21(2):263-7. PubMed ID: 15921068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical technology management: bridging the gap between theory and practice.
    Shemer J; Abadi-Korek I; Seifan A
    Isr Med Assoc J; 2005 Apr; 7(4):211-5. PubMed ID: 15847198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of health technology assessment in decision making: coresponsibility of users and producers?
    Hivon M; Lehoux P; Denis JL; Tailliez S
    Int J Technol Assess Health Care; 2005; 21(2):268-75. PubMed ID: 15921069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health technology assessment.
    Papatheofanis FJ
    Q J Nucl Med; 2000 Jun; 44(2):105-11. PubMed ID: 10967621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.